• Users Online: 737
  • Print this page
  • Email this page


 
 Table of Contents  
REVIEW ARTICLE
Year : 2020  |  Volume : 32  |  Issue : 3  |  Page : 223-226

Is there a role for oxidative stress and mitochondrial dysfunction in age-associated bladder disorders?


Department of Medicine, Renal Electrolyte Division; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA

Date of Submission05-Nov-2019
Date of Acceptance07-Nov-2019
Date of Web Publication03-Jan-2020

Correspondence Address:
Prof. Lori A Birder
Department of Pharmacology and Chemical Biology, University of Pittsburgh, A 1217 Scaife Hall, Pittsburgh, PA 15217
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/tcmj.tcmj_250_19

Rights and Permissions
  Abstract 

Millions of individuals worldwide are affected by age-related lower urinary tract symptoms (LUTSs), including impaired detrusor contractility, detrusor overactivity, decreased bladder sensation, as well as increased bladder capacity often resulting in incomplete bladder emptying. Yet, the underlying factors that contribute to these symptoms are not known and there are few therapies to treat these disorders. Because of the complex pathophysiology, a number of animal models have been studied over the years to better understand mechanisms underlying patient symptoms. Such animal models can aid in the investigation of aspects of age-associated LUTSs that cannot be pursued in humans as well as to develop and test potential therapies. In addition, the search for urinary factors that may be a causative agent has resulted in the discovery of a number of potential targets that could serve as predictive biomarkers which can aid in early diagnosis and treatment of these chronic disorders. Recent evidence has supported a role for chronic changes in mitochondrial function and oxidative stress (along with production of reactive oxygen species) and abnormal urodynamic behavior in older patients. This review discusses new insights into how aging alters fundamental cellular processes that impair signaling in the bladder wall, resulting in abnormal voiding function.

Keywords: Bladder, Mitochondria, Pathophysiology


How to cite this article:
Birder LA. Is there a role for oxidative stress and mitochondrial dysfunction in age-associated bladder disorders?. Tzu Chi Med J 2020;32:223-6

How to cite this URL:
Birder LA. Is there a role for oxidative stress and mitochondrial dysfunction in age-associated bladder disorders?. Tzu Chi Med J [serial online] 2020 [cited 2020 Aug 3];32:223-6. Available from: http://www.tcmjmed.com/text.asp?2020/32/3/223/274837


  Introduction Top


Aging has been defined as the continued loss of homeostatic reserve. It is a complex, biological process controlled by multiple genetic, epigenetic, and environmental factors that result in progressive stress to the cell, tissue, or organ in question [1]. Aging-related bladder dysfunction and lower urinary tract symptoms (LUTSs) represent an increasing problem in developed countries due to increased life expectancy [2],[3]. LUTSs are generally divided into storage (irritative), voiding (obstructive), and postmicturition components. Storage symptoms include urgency, frequency, nocturia, and urgency incontinence (i.e., the overactive bladder syndrome). Voiding symptoms comprise reduced force of stream, hesitancy, inability to empty the bladder, and straining. Postmicturition symptoms include feeling of incomplete emptying and postmicturition dribble. Most of these symptoms have been suggested to be age dependent and attributed to various factors including reduced bladder capacity, changes in bladder sensation, and on urodynamic investigation, detrusor overactivity (DO). However, the pathophysiology behind the dysfunctions is sometimes difficult to establish since what can be attributed to “normal aging” cannot be separated from what is caused by comorbidities. LUTS is an ever-increasing problem: an estimated 45% of the 2008 worldwide population (4.3 billion) was affected by at least one LUTS, reducing the quality of life and this number is expected to significantly increase over time [4].


  Animal Models of Aging-Related Bladder Dysfunction Top


Animal models allow detailed investigation of structural and functional aspects of the micturition pathways and changes occurring with aging. In addition, the genetically modified mouse models allow further understanding and targeting of specific genes. The influence of aging on bladder structure and function has been studied in in vivo and/or in vitro studies performed mostly in rodents of different strains and/or gender. These include C57Bl6 mice, the senescence-accelerated prone mice (SAMP8), Fisher 344 rats, and many others [5],[6],[7],[8],[9],[10]. The relation between aging per se and external influences on the detrusor from diseases in the nervous system, in the vascular supply, and in the lower urinary tract smooth muscles is poorly understood in humans. In animals, kept under constant laboratory conditions, theoretically, the influence of external influences can be reduced, which should enable the study of the effect of age only on bladder function. However, this does not seem to provide consistent results in part due to differences between species, gender, or strain. Cystometry has yielded somewhat more variable results mainly due to species and/or gender differences and/or anesthesia [11],[12]. Ischemia, which is a main risk factor in aging [13],[14], has shown to result in dynamic changes, resembling in the initial phase DO (e.g., increased nonvoiding contractions, increased voiding frequency, and decreased voided volume), and progressing with time to detrusor underactivity (e.g., decreased voiding frequency). Thus, depending on the underlying risk factors, aging may have variable effects on bladder function. Data from animal models, which seem to be as variable as the data from human studies in different clinical conditions, may be useful for understanding the progression of bladder function with age.

Aging is associated with mitochondrial dysfunction and increased oxidative stress

At the cellular level, mitochondria are considered major players in energy production, intracellular communication, and are associated with a number of age-related diseases [15],[16],[17],[18]. Mitochondria, considered the powerhouse of organelles and generate 95% of all cellular energy, play a key role in cellular homeostasis, including generation of reactive oxygen species (ROS), apoptosis, regulation of intracellular calcium, and generation of ATP via oxidative phosphorylation and release of factors that modulate pro- and antiaging signaling pathways. Dysfunctions in mitochondrial metabolic capacity and structural alterations (i.e., accumulation of damaged mitochondria and enhanced cross-linking of proteins) can contribute to oxidative stress and cell death during the aging process.

Oxidative stress is broadly defined as a disturbance in a pro-oxidant–antioxidant balance (i.e., uncontrolled increases in the production of reactive oxygen [or nitrogen] species or deficiencies in antioxidant defense mechanisms), which can lead to potential damage. Oxidative metabolism can yield free radicals and other unstable oxygen- and nitrogen-containing molecules [19],[20],[21],[22]. When produced at low or physiological levels, ROS can regulate a number of processes including maintenance of vascular tone and signal transduction. However, at higher levels, excessive ROS can result in oxidative damage to lipids, proteins, carbohydrates, and DNA, leading to the generation of secondary reactive species and finally loss of function and cell death [19],[20],[21],[22]. ROS (and reactive nitrogen species, RNS) are also generated during radiation therapy, and in the bladder, radiation toxicity generates LUTS [23],[24]. Sources of ROS can include nitric oxide synthase, xanthine oxidase, as well as the mitochondria, an essential supplier of energy. Mitochondria have been described as both a primary source and also target of ROS. ROS is a general term that includes a number of species such as the superoxide anion, which is often increased in conditions of ischemia or hypoxia. Excessive amounts of superoxide can interact with nitric oxide to form peroxynitrite which is a pro-oxidant capable of rapidly diffusing to nearby cells inducing damage. The highly reactive hydroxyl radical is thought to mediate most free radical-induced tissue damage [19],[20],[21],[22].

Mitochondrial DNA (mtDNA) is more susceptible to oxidative damage than nuclear DNA due in part to proximity of mtDNA to the respiratory chain and decreased availability of repair mechanisms [25]. Damage to mtDNA can not only result in mitochondrial dysfunction but also trigger inflammatory and innate immune responses [26],[27]. Studies suggest that oxidative stress also plays a role in fibrotic diseases by augmenting the production of various regulators of fibrosis such as growth factors, angiogenic factors, and cytokines. In the airways, augmented ROS is involved in increased vascular permeability and bronchial hyperresponsiveness, characteristic features of asthma [28],[29]. Because mitochondria are the major consumers of cellular oxygen, it is not surprising that these organelles are significantly impacted by hypoxia and ischemia. Reduced levels of oxygen result in augmented ROS production, decreases energy production and changes in mitochondrial morphology.


  Evaluation of Age-Associated Changes in Lut Form and Function Top


Aging is associated with an impairment of blood vessel function and changes may occur in the vasculature on the molecular, cellular, structural, and functional levels [14]. Endothelial dysfunction leads to oxidative stress and increased levels of pro-inflammatory cytokines, which represents an independent risk factor for the development of atherosclerosis and hypertension. Evidence from epidemiologic, clinical, and animal basic research suggests that aging-associated changes in the pelvic vasculature, resulting in atherosclerosis and vascular dysfunction, may be important factors in the generation of LUTS [30],[31]. Evidence from clinical and basic research suggests that atherosclerosis in both genders can induce a reduction of bladder blood flow, leading to chronic ischemia. Chronic bladder ischemia and repeated ischemia/reperfusion during a micturition cycle may produce oxidative stress and lead to denervation of the bladder and the expression of tissue damaging molecules in the bladder wall [32],[33]. Studies in animal models suggest that the extent of bladder dysfunction in chronic ischemia depends on the degree and duration of ischemia. This appears to be responsible for the development of DO progressing to underactivity and inability to empty the bladder [34]. When bladder ischemia becomes severe and prolonged, progression of denervation and damage to detrusor muscle with fibrosis formation may cause voiding symptoms.

Further, age-related changes in the extracellular matrix (ECM) may also impact the function of tissues in the bladder wall. Despite having different etiologies, most chronic fibrotic disorders produce a persistent production of similar factors including ROS that stimulate ECM production, which progressively destroys the organ's architecture and, in turn, its function [35],[36]. Mitochondria are the primary source of ROS; pathologies associated with mitochondrial dysregulation (including aging) lead to overproduction of ROS, superoxide, and factors that promote fibrosis [37]. As the bladder fills, the coordinated recruitment of collagen fibers across both the smooth muscle and lamina propria layers, essential for the elasticity of the bladder wall, is lost during aging [38]. Further, this impacts the ability of the urothelium to “sense” changes in mechanical deformation that occurs during a micturition cycle and release mediators that may influence sensation.

Much less is known about the effect of aging on urothelial changes. The urothelium, which lines the inner surface of the renal pelvis, ureters, and urinary bladder, not only forms a high-resistance barrier to ion, solute and water flux, and pathogens, but also functions as an integral part of a “sensory web” which receives, amplifies, and transmits information about its external milieu [39],[40]. Structural studies have shown urothelial thinning, granular appearance of the umbrella cell layer often containing what appears to be cellular debris in all layers. These could be the result of oxidative stress and altered mitochondrial dysfunction. In support, increased ROS in cultured urothelial cells, associated with upregulation of transient receptor potential cation channel subfamily M member 8, decreased total antioxidant capacity, and significantly increased levels of lipid peroxides, malondialdehyde, and inducible nitric oxide synthase, all markers of oxidative stress, as well as ultrastructural alterations in mitochondria with accumulation of lipofuscin have been reported [41],[42]. Further, recent studies have revealed an age-related decrease in lysosomal function in urothelium, which may have significant effects on the physiological function of the bladder [43]. Lysosomal dysfunction is associated with a number of age-related pathologies that can affect all organ systems [44],[45]. Lysosomes perform a complex array of functions including promoting the turnover of cellular organelles and proteins and regulation of various activities such as plasma membrane repair [44],[45]. A dysfunction in lysosomal system can have debilitating effects on cellular function as is observed in age-related neurodegenerative diseases including Alzheimer's and Parkinson's. Recent findings showing that lysosomal function is diminished in aging demonstrate that aged (urothelial) cells exhibit a gradual accumulation of metabolic waste products and cellular debris [43]. Defects in this function may alter the homeostatic chemical balance of the urothelium and cellular communication with underlying layers. This in turn could lead to altered detrusor function, manifesting in the various clinical conditions that are observed in the elderly.


  Conclusions and Future Directions Top


While no animal model can be expected to reproduce all the various symptoms experienced by humans, more complex models are needed to mimic the symptoms and systemic changes found in aged patients which include incontinence, overactivity, and/or the inability to empty. Because all aspects of the disease may not be readily addressed by a single animal model, several models may be required, to create a reasonable picture of both pathophysiology and the time course of the disease (which includes temporal changes in biomarkers). While the underlying mechanisms are likely to be complex, they may be controlled in part by multiple genetic, epigenetic, and environmental factors. Further studies are needed to correlate findings in animal models to patient symptoms to provide better insights and new strategies for the clinical management of these bladder disorders. In addition, future translational studies should also consider how changes in bioenergetics and oxidative stress impact bladder aging to develop new therapeutic strategies that may be an important tool to treat age-related bladder control problems.

Financial support and sponsorship

R37 054824 and R01 AG056944.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Smith PP. Aging and the underactive detrusor: A failure of activity or activation? Neurourol Urodyn 2010;29:408-12.  Back to cited text no. 1
    
2.
Dubeau CE. The aging lower urinary tract. J Urol 2006;175:S11-5.  Back to cited text no. 2
    
3.
Pfisterer MH, Griffiths DJ, Schaefer W, Resnick NM. The effect of age on lower urinary tract function: A study in women. J Am Geriatr Soc 2006;54:405-12.  Back to cited text no. 3
    
4.
Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int 2011;108:1132-8.  Back to cited text no. 4
    
5.
Chang SL, Howard PS, Koo HP, Macarak EJ. Role of type III collagen in bladder filling. Neurourol Urodyn 1998;17:135-45.  Back to cited text no. 5
    
6.
Chua WC, Howard PS, Koo HP, Macarak EJ. Age-related changes of P2X(1) receptor mRNA in the bladder detrusor from men with and without bladder outlet obstruction. Exp Gerontol 2007;42:686-92.  Back to cited text no. 6
    
7.
Chun AL, Wallace LJ, Gerald MC, Levin RM, Wein AJ. Effect of age on in vivo urinary bladder function in the rat. J Urol 1988;139:625-7.  Back to cited text no. 7
    
8.
Daly DM, Nocchi L, Liaskos M, McKay NG, Chapple C, Grundy D, et al. Age-related changes in afferent pathways and urothelial function in the male mouse bladder. J Physiol 2014;592:537-49.  Back to cited text no. 8
    
9.
Triguero D, Lafuente-Sanchis A, Garcia-Pascual A. Changes in nerve-mediated contractility of the lower urinary tract in a mouse model of premature ageing. Br J Pharmacol 2014;171:1687-705.  Back to cited text no. 9
    
10.
Kohan AD, Danziger M, Vaughan ED Jr., Felsen D. Effect of aging on bladder function and the response to outlet obstruction in female rats. Urol Res 2000;28:33-7.  Back to cited text no. 10
    
11.
Smith PP, DeAngelis A, Kuchel GA. Detrusor expulsive strength is preserved, but responsiveness to bladder filling and urinary sensitivity is diminished in the aging mouse. Am J Physiol Regul Integr Comp Physiol 2012;302:R577-86.  Back to cited text no. 11
    
12.
Zhao W, Aboushwareb T, Turner C, Mathis C, Bennett C, Sonntag WE, et al. Impaired bladder function in aging male rats. J Urol 2010;184:378-85.  Back to cited text no. 12
    
13.
Ungvari Z, Kaley G, de Cabo R, Sonntag WE, Csiszar A. Mechanisms of vascular aging: New perspectives. J Gerontol A Biol Sci Med Sci 2010;65:1028-41.  Back to cited text no. 13
    
14.
Oakley R, Tharakan B. Vascular hyperpermeability and aging. Aging Dis 2014;5:114-25.  Back to cited text no. 14
    
15.
Bereiter-Hahn J. Do we age because we have mitochondria? Protoplasma 2014;251:3-23.  Back to cited text no. 15
    
16.
Harman D. The biologic clock: The mitochondria? J Am Geriatr Soc 1972;20:145-7.  Back to cited text no. 16
    
17.
Lane RK, Hilsabeck T, Rea SL. The role of mitochondrial dysfunction in age-related diseases. Biochim Biophys Acta 2015;1847:1387-400.  Back to cited text no. 17
    
18.
Harman D. Aging: A theory based on free radical and radiation chemistry. J Gerontol 1956;11:298-300.  Back to cited text no. 18
    
19.
Halliwell B, Gutteridge JM. Free Radicals in biology and medicine. 5th ed. Oxford: Oxford University Press; 2015.  Back to cited text no. 19
    
20.
Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 2000;29:222-30.  Back to cited text no. 20
    
21.
Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315-424.  Back to cited text no. 21
    
22.
Richter C, Park JW, Ames BN. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci U S A 1988;85:6465-7.  Back to cited text no. 22
    
23.
Marks LB, Carroll PR, Dugan TC, Anscher MS. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 1995;31:1257-80.  Back to cited text no. 23
    
24.
Özyurt H, Çevik Ö, Özgen Z, Özden AS, Çadırcı S, Elmas MA, et al. Quercetin protects radiation-induced DNA damage and apoptosis in kidney and bladder tissues of rats. Free Radic Res 2014;48:1247-55.  Back to cited text no. 24
    
25.
Herrero A, Barja G. Effect of aging on mitochondrial and nuclear DNA oxidative damage in the heart and brain throughout the life-span of the rat. J Am Aging Assoc 2001;24:45-50.  Back to cited text no. 25
    
26.
Chen Y, Zhou Z, Min W. Mitochondria, oxidative stress and innate immunity. Front Physiol 2018;9:1487.  Back to cited text no. 26
    
27.
Krysko DV, Agostinis P, Krysko O, Garg AD, Bachert C, Lambrecht BN, et al. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 2011;32:157-64.  Back to cited text no. 27
    
28.
Riedl MA, Nel AE. Importance of oxidative stress in the pathogenesis and treatment of asthma. Curr Opin Allergy Clin Immunol 2008;8:49-56.  Back to cited text no. 28
    
29.
Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008;214:199-210.  Back to cited text no. 29
    
30.
Takahashi N, Shishido K, Sato Y, Ogawa S, Oguro T, Kataoka M, et al. The association between severity of atherosclerosis and lower urinary tract function in male patients with lower urinary tract symptoms. Low Urin Tract Symptoms 2012;4:9-13.  Back to cited text no. 30
    
31.
Pinggera GM, Mitterberger M, Steiner E, Pallwein L, Frauscher F, Aigner F, et al. Association of lower urinary tract symptoms and chronic ischaemia of the lower urinary tract in elderly women and men: Assessment using colour Doppler ultrasonography. BJU Int 2008;102:470-4.  Back to cited text no. 31
    
32.
Brading AF, Greenland JE, Mills IW, McMurray G, Symes S. Blood supply to the bladder during filling. Scand J Urol Nephrol Suppl 1999;201:25-31.  Back to cited text no. 32
    
33.
Azadzoi KM, Chen BG, Radisavljevic ZM, Siroky MB. Molecular reactions and ultrastructural damage in the chronically ischemic bladder. J Urol 2011;186:2115-22.  Back to cited text no. 33
    
34.
Nomiya M, Yamaguchi O, Akaihata H, Hata J, Sawada N, Kojima Y, et al. Progressive vascular damage may lead to bladder underactivity in rats. J Urol 2014;191:1462-9.  Back to cited text no. 34
    
35.
Karsdal MA, Nielsen MJ, Sand JM, Henriksen K, Genovese F, Bay-Jensen AC, et al. Extracellular matrix remodeling: The common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure. Assay Drug Dev Technol 2013;11:70-92.  Back to cited text no. 35
    
36.
Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci 2010;123:4195-200.  Back to cited text no. 36
    
37.
Akbari M, Kirkwood TB, Bohr VA. Mitochondria in the signaling pathways that control longevity and health span. Ageing Res Rev 2019;54:100940.  Back to cited text no. 37
    
38.
Cheng F, Birder LA, Kullmann FA, Hornsby J, Watton PN, Watkins S, et al. Layer-dependent role of collagen recruitment during loading of the rat bladder wall. Biomech Model Mechanobiol 2018;17:403-17.  Back to cited text no. 38
    
39.
Birder L, Andersson KE. Urothelial signaling. Physiol Rev 2013;93:653-80.  Back to cited text no. 39
    
40.
Khandelwal P, Abraham SN, Apodaca G. Cell biology and physiology of the uroepithelium. Am J Physiol Renal Physiol 2009;297:F1477-501.  Back to cited text no. 40
    
41.
Nocchi L, Daly DM, Chapple C, Grundy D. Induction of oxidative stress causes functional alterations in mouse urothelium via a TRPM8-mediated mechanism: Implications for aging. Aging Cell 2014;13:540-50.  Back to cited text no. 41
    
42.
Perše M, Injac R, Erman A. Oxidative status and lipofuscin accumulation in urothelial cells of bladder in aging mice. PLoS One 2013;8:e59638.  Back to cited text no. 42
    
43.
Truschel ST, Clayton DR, Beckel JM, Yabes JG, Yao Y, Wolf-Johnston A, et al. Age-related endolysosome dysfunction in the rat urothelium. PLoS One 2018;13:e0198817.  Back to cited text no. 43
    
44.
Xu H, Ren D. Lysosomal physiology. Annu Rev Physiol 2015;77:57-80.  Back to cited text no. 44
    
45.
Kundu M, Thompson CB. Autophagy: Basic principles and relevance to disease. Annu Rev Pathol 2008;3:427-55.  Back to cited text no. 45
    




 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Animal Models of...
Evaluation of Ag...
Conclusions and ...
References

 Article Access Statistics
    Viewed700    
    Printed39    
    Emailed0    
    PDF Downloaded85    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]